Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page shows a new revision label of v3.6.6, replacing v3.6.5. This indicates a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-09-01T19:47:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4 tag. This indicates a page version update rather than a substantive change to the trial details.
    Difference
    0.1%
    Check dated 2026-08-11T06:21:24.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a platform release. It does not modify study content or data on the page.
    Difference
    0.1%
    Check dated 2026-07-28T05:27:25.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A platform revision was applied, updating the site from version 3.6.2 to 3.6.3. This is a backend software update that does not change the study content.
    Difference
    0.1%
    Check dated 2026-07-06T16:38:42.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study record page.
    Difference
    0.1%
    Check dated 2026-06-29T08:53:18.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The recruitment status on the page was updated to show that enrollment is closed (No longer looking for participants), clarifying that the study is not accepting new participants.
    Difference
    0.4%
    Check dated 2026-06-15T08:34:16.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.